145 results on '"Harjola, Veli-Pekka"'
Search Results
2. miR‐619‐5p and cardiogenic shock in patients with ST‐segment elevation myocardial infarction
3. Diagnosis and treatment of right ventricular failure secondary to acutely increased right ventricular afterload (acute cor pulmonale). A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC
4. Speed and Nighttime Usage Restrictions and the Incidence of Shared Electric Scooter Injuries
5. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
6. Red cell distribution width and mortality in older patients with frailty in the emergency department
7. PROGNOSTIC VALUE OF CIRCULATING SECRETONEURIN CONCENTRATIONS IN PATIENTS WITH CARDIOGENIC SHOCK: THE CARDSHOCK STUDY
8. Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland
9. Performance of Early Capillary Refill Time Measurement on Outcomes in Cardiogenic Shock: An Observational, Prospective Multicentric Study
10. Characteristics and costs of electric scooter injuries in Helsinki: a retrospective cohort study
11. Characteristics and costs of electric scooter injuries in Helsinki: a retrospective cohort study
12. Low body temperature and mortality in older patients with frailty in the emergency department
13. Acute Heart Failure
14. Effect of Inhaled Xenon on Cardiac Function in Comatose Survivors of Out-of-Hospital Cardiac Arrest—A Substudy of the Xenon in Combination With Hypothermia After Cardiac Arrest Trial
15. Systematic geriatric assessment for older patients with frailty in the emergency department: a randomised controlled trial
16. Outcome of patients with different clinical presentations of high-risk pulmonary embolism
17. Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism
18. Reply to: High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
19. The Emergency Department Arrival Mode and Its Relations to ED Management and 30-Day Mortality in Acute Heart Failure: An Ancillary Analysis From The EURODEM Study
20. Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock – Insights from the CardShock study
21. Seasonal variations of patients presenting dyspnea to emergency departments in Europe: Results from the EURODEM Study
22. National Early Warning Score 2 (NEWS2) and 3-level triage scale as risk predictors in frail older adults in the emergency department
23. National Early Warning Score 2 (NEWS2) and 3-Level Triage Scale as Risk Predictors in Frail Older Adults in the Emergency Department
24. National Early Warning Score 2 (NEWS2) and 3-level Triage Scale as Risk Predictors in Frail Older Adults in the Emergency Department
25. Survival and quality of life after early discharge in low-risk pulmonary embolism
26. Epidemiology, treatment and outcome of patients with lower respiratory tract infection presenting to emergency departments with dyspnoea ( AANZDEM and EuroDEM studies)
27. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology
28. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
29. External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients
30. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology
31. Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock
32. Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology
33. Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics
34. CT‐IGFBP‐4 as a novel prognostic biomarker in acute heart failure
35. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
36. Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
37. Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock
38. Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
39. Epidemiology of patients presenting with dyspnea to emergency departments in Europe and the Asia-Pacific region
40. Dinámica de microARN circulantes en pacientes con infarto agudo de miocardio con elevación del segmento ST con shock cardiogénico
41. Circulating MiRNA Dynamics in ST-Segment Elevation Myocardial Infarction-driven Cardiogenic Shock
42. Pulmonary embolism location is associated with the co-existence of the deep venous thrombosis
43. Protein-based cardiogenic shock patient classifier
44. Rapid cardiothoracic ultrasound protocol for diagnosis of acute heart failure in the emergency department
45. Treatment and outcome of adult patients with acute asthma in emergency departments in Australasia, South East Asia and Europe: Are guidelines followed? AANZDEM/EuroDEM study
46. Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study
47. Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation
48. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology
49. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology
50. Use of levosimendan in acute heart failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.